Geode Capital Management, LLC Scynexis Inc Transaction History

Geode Capital Management, LLC

$1.24 Trillion
Q1 2025

A detailed history of Geode Capital Management, LLC transactions in Scynexis Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 419,488 shares of SCYX stock, worth $306,226. This represents 0.0% of its overall portfolio holdings.

Number of Shares

419,488

Previous 405,064 3.56%

Holding current value

$306,226

Previous $465,000 14.41%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$0.9 - $1.41 $12,981 - $20,337	14,424 Added 3.56%	419,488 $398,000
Q4 2024 Feb 12, 2025	BUY	$1.0 - $1.53 $6,208 - $9,498	6,208 Added 1.56%	405,064 $465,000
Q3 2024 Nov 12, 2024	BUY	$1.27 - $2.23 $46,234 - $81,183	36,405 Added 10.04%	398,856 $594,000
Q2 2024 Aug 09, 2024	BUY	$1.4 - $2.77 $10,137 - $20,057	7,241 Added 2.04%	362,451 $724,000
Q1 2024 May 13, 2024	SELL	$1.39 - $2.21 $977 - $1,553	-703 Reduced 0.2%	355,210 $522,000
Q4 2023 Feb 13, 2024	BUY	$1.56 - $2.24 $26,474 - $38,015	16,971 Added 5.01%	355,913 $793,000
Q3 2023 Nov 13, 2023	BUY	$1.93 - $3.64 $51,700 - $97,508	26,788 Added 8.58%	338,942 $772,000
Q2 2023 Aug 11, 2023	BUY	$2.38 - $3.67 $109,779 - $169,282	46,126 Added 17.34%	312,154 $920,000
Q4 2022 Feb 13, 2023	SELL	$1.46 - $2.94 $24,476 - $49,289	-16,765 Reduced 5.93%	266,028 $415,000
Q3 2022 Nov 14, 2022	BUY	$1.83 - $2.93 $91,624 - $146,699	50,068 Added 21.51%	282,793 $678,000
Q2 2022 Aug 12, 2022	BUY	$1.77 - $3.87 $37,231 - $81,405	21,035 Added 9.94%	232,725 $432,000
Q1 2022 May 13, 2022	BUY	$3.56 - $6.66 $137,939 - $258,055	38,747 Added 22.4%	211,690 $827,000
Q4 2021 Feb 11, 2022	BUY	$4.94 - $7.69 $66,793 - $103,976	13,521 Added 8.48%	172,943 $1.05 Million
Q3 2021 Nov 12, 2021	SELL	$5.3 - $7.89 $25,090 - $37,351	-4,734 Reduced 2.88%	159,422 $844,000
Q2 2021 Aug 13, 2021	BUY	$6.5 - $9.97 $186,251 - $285,680	28,654 Added 21.15%	164,156 $1.21 Million
Q1 2021 May 12, 2021	BUY	$6.93 - $9.63 $428,086 - $594,873	61,773 Added 83.78%	135,502 $1.08 Million
Q4 2020 Feb 12, 2021	BUY	$4.28 - $7.87 $25,919 - $47,660	6,056 Added 8.95%	73,729 $564,000
Q3 2020 Nov 13, 2020	BUY	$4.37 - $7.48 $295,731 - $506,194	67,673 New	67,673 $298,000

Others Institutions Holding SCYX

# of Institutions

Shares Held

12.2M

Call Options Held

Put Options Held

View Full List

About SCYNEXIS INC

Ticker SCYX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 32,651,800
Market Cap $23.8M
Description
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...

More about SCYX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Scynexis Inc Transaction History